Novo Nordisk Long-Term Investments 2010-2024 | NVO

Novo Nordisk long-term investments for the quarter ending September 30, 2024 were $0.302B, a 40.49% increase year-over-year.

  • Novo Nordisk long-term investments for 2023 were $0.241B, a 26.98% increase from 2022.
  • Novo Nordisk long-term investments for 2022 were $0.19B, a 17.05% decline from 2021.
  • Novo Nordisk long-term investments for 2021 were $0.229B, a 9.19% decline from 2020.

Novo Nordisk Long-Term Investments 2010-2024 | NVO

  • Novo Nordisk long-term investments for 2023 were $0.241B, a 26.98% increase from 2022.
  • Novo Nordisk long-term investments for 2022 were $0.19B, a 17.05% decline from 2021.
  • Novo Nordisk long-term investments for 2021 were $0.229B, a 9.19% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B